Search results for "Time Factors."

showing 10 items of 3213 documents

Integrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial

2014

Background: The integrated treatment of first episode psychosis has been shown to improve functionality and negative symptoms in previous studies. In this paper, we describe a study of integrated treatment (individual psychoeducation complementary to pharmacotherapy) versus treatment as usual, comparing results at baseline with those at 6-month re-assessment (at the end of the study) for these patients, and online training of professionals to provide this complementary treatment, with the following objectives: 1) to compare the efficacy of individual psychoeducation as add-on treatment versus treatment as usual in improving psychotic and mood symptoms; 2) to compare adherence to medication,…

Time Factorsmedicine.medical_treatmentGlobal Assessment of FunctioningMedicine (miscellaneous)Liebowitz social anxiety scaleWeb-based instructionlaw.inventionStudy Protocolmulticenter trialClinical ProtocolsRandomized controlled triallawSurveys and QuestionnairesSingle-Blind MethodPharmacology (medical)PHARMACOLOGY (MEDICAL)validationPositive and Negative Syndrome ScaleCombined Modality TherapyTreatment OutcomeResearch Designspanish versionAprenentatge electrònicAnxietymedicine.symptomAntipsychotic Agentsmedicine.medical_specialtyPsicosiMedication Adherencescale1st-episode psychosisPredictive Value of TestsPsychoeducationmedicineHumansSocial BehaviorPsychiatryPsychiatric Status Rating ScalesInternetbusiness.industryMEDICINEBrain-Derived Neurotrophic FactorHamilton Rating Scale for DepressionPsychoses5-year follow-upstandard treatementPsychotherapyAffectLogistic ModelsMoodPsychotic Disordersopus trialSpainquality-of-lifeLinear ModelsQuality of Lifebusinesscognitive-behavior therapyBiomarkersComputer-Assisted InstructionTrials
researchProduct

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

1997

Abstract The current study was carried out to elucidate the immunoregulatory changes induced by venom immunotherapy (VIT) in bee or wasp allergic subjects. All subjects included in this study had a history of severe systemic allergic reactions to stings of the respective insect as well as positive skin tests with the respective venom or venom-specific IgE in the sera. Parameters assessed in peripheral blood mononuclear cells (PBMC) before and after initiation of VIT (rush therapy reaching a maintenance dose of 100 micrograms venom injected subcutaneously within 1 week) were expression of CD3, CD4, CD8, CD45RA, CD45RO, interleukin (IL)-2 receptor (R) alpha, IL-4R, IL-12R, Fc epsilon RII, CD4…

Time Factorsmedicine.medical_treatmentImmunologyCD40 LigandDown-RegulationVenomWasp VenomsImmunoglobulin ELigandsLymphocyte ActivationPeripheral blood mononuclear cellInterferon-gammaTh2 CellsAntigens CDT-Lymphocyte SubsetsmedicineImmunology and AllergyHumansLymphocyte CountRNA MessengerCD40 AntigensCD40Membrane GlycoproteinsbiologyReceptors IgEInterleukinAntibodies MonoclonalInsect Bites and StingsReceptors InterleukinAllergensTh1 CellsInterleukin-10Receptors Interleukin-4Interleukin 10Bee VenomsCytokineDesensitization ImmunologicImmunologyAntigens Surfacebiology.proteinInterleukin-4AntibodyEuropean journal of immunology
researchProduct

Analysing the Spanish smoke-free legislation of 2006: a new method to quantify its impact using a dynamic model.

2011

Background: There are many models that study aspects of smoking habits: the influence of price, tax, relapse time, and the effects of prohibition. There are also studies examining the effects of the Spanish smoke-free law. We wanted to build a model able to separate the effect of the law from the pre-law evolution of smoking habits. Methods: Using data from the Spanish Ministry of Health and Social Policy, we developed a dynamic model of tobacco use. The model projects the evolution over time of the number of non-smokers, smokers and ex-smokers before 2006. Then, we compared the predictions of the model with data for the years after the law came into force, 2006 and 2009. Results: We show t…

Time Factorsmedicine.medical_treatmentMedicine (miscellaneous)Smoking PreventionSmoking cessationHealth policy evaluationMathematical modelRecurrencePrevalenceSecondary PreventionSmoking habitWorkplaceSmoke free legislationhealth care economics and organizationsmedia_commonSocial policyPriority journalPublic healthHealth PolicySmokingTobacco Use DisorderMiddle AgedTobacco smokingPolicybehavior and behavior mechanismsMATEMATICA APLICADASimulationHumanAdultmedicine.medical_specialtyAdolescentmedia_common.quotation_subjectHealth PromotionModels PsychologicalArticleSmoke free legislationYoung AdultEnvironmental healthmedicineHumansComputer SimulationHealth policyAgedbusiness.industryPublic healthGovernment regulationWork (physics)Health Surveysrespiratory tract diseasesHealth promotionSpainSmoking cessationSimulation modelSmoking CessationTobacco Smoke PollutionHabitbusinessPredictionControlled studyLawDemographyThe International journal on drug policy
researchProduct

Prostaglandin E(2)-loaded microspheres as strategy to inhibit phagocytosis and modulate inflammatory mediators release.

2008

PGE(2), an arachidonic acid metabolite produced by various type of cells regulates a broad range of physiological activities in the endocrine, cardiovascular, gastrointestinal, and immune systems, and is involved in maintaining the local homeostasis. In the immune system, PGE(2) is mainly produced by APCs and it can suppress the Th1-mediated immune responses. The aim of this study was to develop PGE(2)-loaded biodegradable MS that prolong and sustain the in vivo release of this mediator. An o/w emulsion solvent extraction-evaporation method was chosen to prepare the MS. We determined their diameters, evaluated the in vitro release of PGE(2), using enzyme immunoassay and MS uptake by periton…

Time Factorsmedicine.medical_treatmentPhagocytosisChemistry PharmaceuticalDrug CompoundingPharmaceutical ScienceInflammationPharmacologyBiologyNitric OxideDinoprostonechemistry.chemical_compoundMiceImmune systemPhagocytosisIn vivoSepsismedicineAnimalsHumansImmunologic FactorsProstaglandin E2Particle SizeCells CulturedChemokine CCL2Tumor Necrosis Factor-alphaEndothelial CellsWaterGeneral MedicineMicrospheresDisease Models AnimalchemistryBiochemistrySolubilityDelayed-Action PreparationsMacrophages PeritonealLiberationlipids (amino acids peptides and proteins)Arachidonic acidEmulsionsmedicine.symptomInflammation MediatorsOilsBiotechnologyProstaglandin Emedicine.drugEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo

2005

Deregulation of apoptosis signalling is commonly found in cancer and results in resistance to cytotoxic therapies. Immunotherapy is a promising strategy to eliminate resistant cancer cells. The transfer of T-lymphocytes during allogeneic stem cell transplantation is clinically explored to induce a 'graft-versus-tumor' effect (GvT). Cytotoxic T-lymphocytes (CTL), which are major effectors of GvT, eliminate cancer cells by inducing apoptosis via multiple parallel pathways. Here, we study in vitro and in vivo the susceptibility of murine cancer cells engineered to express single antiapoptotic genes to CTL-mediated cytotoxicity. Interestingly, we find that single inhibitors of caspase activatio…

Time Factorsmedicine.medical_treatmentbcl-X ProteinApoptosisMice TransgenicMiceHLA-A2 AntigenTumor Cells CulturedmedicineAnimalsCytotoxic T cellFADDMolecular BiologybiologyCancerCell BiologyImmunotherapymedicine.diseaseAdoptive TransferMitochondriaEnzyme ActivationTransplantationCTL*Proto-Oncogene Proteins c-bcl-2CaspasesCancer cellImmunologybiology.proteinCancer researchTumor Suppressor Protein p53Stem cellT-Lymphocytes CytotoxicCell Death & Differentiation
researchProduct

Risk Burden of Coronary Perforation in Chronic Total Occlusion Recanalization: Latin American CTO Registry Analysis

2022

Background Coronary perforation is a life‐threatening complication of acute percutaneous coronary intervention (PCI) for chronic total occlusions (CTO), but data on midterm outcomes are limited. Methods and Results Data from LATAM (Latin American)‐CTO Registry (57 centers; 9 countries) were analyzed. We assessed the risk of 30‐day, 1‐year major adverse cardiac events of coronary perforation using time‐to‐event and weighted composite end point analysis having CTO PCI without perforation as comparators. Additionally, we studied the independent predictors of perforation in these patients. Of 2054 patients who underwent CTO PCI between 2015 and 2018, the median Multicenter CTO Registry in Japa…

Time Factorspercutaneous coronary interventionacute myocardial infarctionCoronary Angiographytarget vessel revascularization.Latin AmericaTreatment OutcomeHeart InjuriesRisk FactorsChronic DiseaseHumansProspective StudiesRegistriescoronary perforationCardiology and Cardiovascular Medicinechronic total occlusionJournal of the American Heart Association
researchProduct

A thin layer-based amperometric enzyme immunoassay for the rapid and sensitive diagnosis of respiratory syncytial virus infections

2012

Abstract A simple electrochemical sandwich immunoassay involving a polystyrene microarray slide coated with monoclonal capture antibodies and carbon screen-printed sensors (SPS) was designed for the rapid diagnosis of respiratory syncytial virus (RSV). The detection of the antibody-antigen complex formation relied on the use of a horseradish peroxidase conjugate. Its chronoamperometric measurement detection was performed by confining a droplet of H 2 O 2 /3,3',5,5'-tetramethylbenzidine enzyme substrate/mediator solution within a thin layer between one spot of the microarray and the surface of one screen-printed electrochemical cell. The accumulation of the enzyme product in the thin film of…

Time Factorsrespiratory syncytial virus[SDV]Life Sciences [q-bio]Biosensing TechniquesRespiratory Syncytial Virus Infectionsscreen-printed sensorSensitivity and SpecificityHorseradish peroxidaseVirusAnalytical ChemistryImmunoenzyme TechniquesElectrochemistrymedicineHumans[SDV.BV]Life Sciences [q-bio]/Vegetal BiologyimmunoassayAntigens ViralHorseradish PeroxidaseChromatographybiologymedicine.diagnostic_testChemistryAntibodies MonoclonalRespiratory infectionSubstrate (chemistry)Molecular biologyAmperometryRespiratory Syncytial VirusesHRP labelImmunoassay[SDE]Environmental Sciencesbiology.proteinColorimetrythin layer amperometric detectionAntibodyConjugate
researchProduct

Time-Gated Raman Spectroscopy for Quantitative Determination of Solid-State Forms of Fluorescent Pharmaceuticals

2018

Raman spectroscopy is widely used for quantitative pharmaceutical analysis, but a common obstacle to its use is sample fluorescence masking the Raman signal. Time-gating provides an instrument-based method for rejecting fluorescence through temporal resolution of the spectral signal and allows Raman spectra of fluorescent materials to be obtained. An additional practical advantage is that analysis is possible in ambient lighting. This study assesses the efficacy of time-gated Raman spectroscopy for the quantitative measurement of fluorescent pharmaceuticals. Time-gated Raman spectroscopy with a 128 X (2) X 4 CMOS SPAD detector was applied for quantitative analysis of ternary mixtures of sol…

Time Factorsspektroskopia116 Chemical sciencesAnalytical chemistry02 engineering and technologySpectrum Analysis Raman01 natural sciencesSignalAnalytical Chemistrysymbols.namesakeTime domainLeast-Squares Analysista116DETECTORFluorescent DyesSUPPRESSIONta113ta114Chemistry010401 analytical chemistryDetectorMIXTURESSENSORPIROXICAMRESONANCE021001 nanoscience & nanotechnologyRAY-POWDER DIFFRACTIONFluorescence0104 chemical sciencesSPADPharmaceutical PreparationsPHOTON AVALANCHE-DIODETemporal resolutionRaman spectroscopysymbolsCRYSTALLIZATION0210 nano-technologyRaman spectroscopyTernary operationQuantitative analysis (chemistry)
researchProduct

D2R striatopallidal neurons inhibit both locomotor and drug reward processes.

2009

The specific functions of dopamine D(2) receptor-positive (D(2)R) striatopallidal neurons remain poorly understood. Using a genetic mouse model, we found that ablation of D(2)R neurons in the entire striatum induced hyperlocomotion, whereas ablation in the ventral striatum increased amphetamine conditioned place preference. Thus D(2)R striatopallidal neurons limit both locomotion and, unexpectedly, drug reinforcement.

Time FactorsstriatumParkinson's diseaseStriatumNeurons -- drug effectsEnkephalins -- metabolism10263 Institute of Experimental ImmunologyMiceDopamine Uptake InhibitorsTyrosine 3-Monooxygenase -- geneticsCorpus Striatum -- cytologyDiphtheria ToxinGlutamate Decarboxylase -- metabolismstriatum; indirect opathway; A2A receptors; D2 receptors; locomotion; amphetamine addiction; Parkinson's diseaseNeuronsamphetamine addictionGlutamate DecarboxylaseGeneral NeuroscienceAmphetamine -- pharmacologyNeurodegeneration2800 General NeuroscienceEnkephalinsSciences bio-médicales et agricoleslocomotionmedicine.anatomical_structureA2A receptorsIntercellular Signaling Peptides and ProteinsReceptors Dopamine D2 -- metabolismPsychologyLocomotionmedicine.drugHeparin-binding EGF-like Growth FactorProtein BindingGlobus Pallidus -- cytologyReceptors Dopamine D2 -- deficiencyReinforcement ScheduleTyrosine 3-MonooxygenaseGlutamate Decarboxylase -- geneticsLocomotion -- geneticsIntercellular Signaling Peptides and Proteins -- genetics610 Medicine & healthMice TransgenicNerve Tissue ProteinsDiphtheria Toxin -- pharmacologyGlobus PallidusNeurons -- physiologyLocomotion -- drug effectsRewardDopamineDopamine receptor D2medicineNerve Tissue Proteins -- metabolismAnimalsGene Expression Regulation -- geneticsAmphetamineD2 receptorsReceptors Adenosine A2Receptors Dopamine D2indirect opathwayVentral striatumReceptors Adenosine A2 -- geneticsDopamine Uptake Inhibitors -- pharmacologymedicine.diseaseConditioned place preferenceCorpus StriatumMice Inbred C57BLGene Expression Regulation -- drug effectsAmphetaminenervous systemGene Expression RegulationProtein Binding -- drug effectsTyrosine 3-Monooxygenase -- metabolism570 Life sciences; biologyAutoradiographyConditioning OperantNeuronConditioning Operant -- physiologyNeuroscienceEnkephalins -- geneticsNature neuroscience
researchProduct

Sub-lethal effects of deltamethrin on walking behaviour and response to host kairomone of the egg parasitoid Trissolcus basalis.

2002

The lethal doses of the pyrethroid deltamethrin were estimated for the egg parasitoid Trissolcus basalis (Wollaston) (Hymenoptera: Scelionidae), and the sub-lethal effects of an LD25 on female walking behaviour were evaluated. Linear speed of treated parasitoids was reduced compared with that of untreated ones for a period of up to 24 h. The sub-lethal effects of deltamethrin on parasitoid response to patches contaminated by a contact kairomone from its host, Nezara viridula L (Heteroptera: Pentatomidae), was also evaluated. Both treated and untreated parasitoids responded to host-contaminated patches by increasing residence time and decreasing linear speed. However, treated females showed …

Time Factorssub-letal effectHymenopteraMotor ActivityPheromonesParasitoidHeteropterachemistry.chemical_compoundAnimal scienceparasitic diseasesBotanyNitrilesPyrethrinsAnimalsTrissolcus basalisScelionidaePyrethroidbiologyDose-Response Relationship DrugkairomonefungiNezara viriduladeltamethrinGeneral MedicinePentatomidaebiology.organism_classificationHymenopteraDeltamethrinLogistic ModelsNezara viridula; Trissolcus basalis; egg parasitoid; kairomone; sub-letal effect; deltamethrinchemistryNezara viridulaInsect ScienceKairomoneegg parasitoidFemaleAgronomy and Crop ScienceLocomotionPest management science
researchProduct